PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

Title
PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Authors
Keywords
Metastatic prostate cancer, Prostate-specific membrane antigen (PSMA), PET/CT, [<sup>18</sup>F]DCFPyL, Computed tomography (CT), Bone scan
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume 18, Issue 3, Pages 411-419
Publisher
Springer Nature
Online
2016-04-15
DOI
10.1007/s11307-016-0957-6

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started